Blockman, MCohen, KDe Waal, RGray, AKredo, TMaartens, GNel, JParrish, ARees, HReubenson, G2024-09-252024-09-252021-01-25https://www.health.gov.za/wp-content/uploads/2021/07/Rapid-review-of-Ivermectin-for-COVID-19-Update_18June2021-ADDENDUM.pdfhttps://hdl.handle.net/11288/597490Ivermectin is an antiparasitic drug that is commonly used for the treatment and prophylaxis of onchocerciasis and treatment of strongyloidiasis and intractable scabies. Ivermectin is not approved, globally, as an antiviral agent.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/IvermectinCOVID-19SARS-CoV-2Systematic reviewRapid reviewTherapyRemedyTreatmentIvermectin for treatment of COVID-19: Evidence review of clinical benefits and harmsTechnical Report